NCT02230371View on ClinicalTrials.gov

Study on the Effect of Granisetron on Myofascial Pain in the Orofacial Muscles

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

October 31, 2014

Study Completion Date

December 31, 2014

Conditions
Myofascial PainTemporomandibular Disorders
Interventions
DRUG

Granisetron

If the patient does not have any pain after the first or second injection of granisetron (Kytril®; 1 mg/mL, Roche, Stockholm, Sweden), there will be no more injections but the patient will still come for the follow ups.

DRUG

Control (placebo)

If the patient does not have any pain after the first or second injection of granisetron (isotonic saline (NaCl); 0.9 mg/mL, Fresenius Kabi, Uppsala, Sweden), there will be no more injections but the patient will still come for the follow ups.

Trial Locations (1)

141 04

Karolinska Institutet, Department of Dental Medicine, Huddinge

All Listed Sponsors
collaborator

Folktandvården Stockholms län AB

OTHER_GOV

lead

Karolinska Institutet

OTHER

NCT02230371 - Study on the Effect of Granisetron on Myofascial Pain in the Orofacial Muscles | Biotech Hunter | Biotech Hunter